Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2021˜The œNephron journals/Nephron journalsOpen Access

Biomarker-Based Management of AKI: Fact or Fantasy?

View Full Paper
Ask AI
Bookmark
Share

Authors

MOMarlies OstermannUniversity of SienaEKEmma KarstenGuy's and St Thomas' NHS Foundation TrustNLNuttha LumlertgulChulalongkorn University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ostermann et al. (2021) studied this question.

synapsesocial.com/papers/6a6c68c401245da06ecbcf64https://doi.org/10.1159/000518365
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial2021 · 303 citations
  2. 2Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery2012 · 303 citations
  3. 3Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel2019 · 86 citations
  4. 4Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial2017 · 912 citations
  5. 5Assessment of KDIGO Definitions in Patients with Histopathologic Evidence of Acute Renal Disease2014 · 107 citations